Granzyme B PET Imaging Inflammation and Remodeling in Myocardial Infarction.

Hongchuang Xu,Zhuxin Wei,Bixi Chen,Jiaxin Wang,Haoyu Weng,Jianping Li,Xing Yang,Shihua Zhao
DOI: https://doi.org/10.1007/s00259-023-06521-9
2024-01-01
Abstract:This study aimed to evaluate whether granzyme B (GzmB)-targeted positron emission tomography (PET) imaging agent (68 Ga-grazytracer) can characterize cardiac inflammation and remodeling in myocardial infarction (MI). Rats with MI were subjected to GzmB-targeted PET/CT on post-operative days 1, 3, 6, 14, and 28. Autoradiography, Masson staining, immunohistochemistry, and ELISA were performed to verify the inflammatory response and remodeling after MI in vitro. Rats were treated with GzmB inhibitor Z-IETD-FMK to improve cardiac remodeling. Cardiac function tests were performed by echocardiography at 6 weeks after MI. The highest uptake of 68 Ga-grazytracer was observed on day 3 after MI compared with the values obtained on the other days (0.294 ± 0.03
What problem does this paper attempt to address?